Zero-Trust Healthcare Fieldwork: NPI Verification, EphMRA Ethics, and Adverse Event Pharmacovigilance

Healthcare and biopharmaceutical market research operates under the most stringent regulatory scrutiny in the insights industry. When pharmaceutical brands evaluate next-generation oncology therapies or rare disease protocols, sample contamination can compromise clinical strategy and regulatory compliance.

1. Multi-Registry API Validation

Scrutiny Global maintains real-time API integrations with national medical registries including the National Provider Identifier (NPI) in the United States, the General Medical Council (GMC) in the United Kingdom, and the Ordre des Médecins in France. Every physician respondent is validated against active license status and verified practice sub-specialty before entering the survey router.

2. 24-Hour Pharmacovigilance Adverse Event Protocols

In accordance with EphMRA and FDA guidelines, our survey scripting technology includes automated NLP semantic parsing to identify spontaneous disclosures of Adverse Events (AEs), product complaints, or off-label toxicity. Any detected event triggers an immediate encrypted notification forwarded to client safety desks within 24 hours.